Retractable needle safety syringes market seen reaching $8.13 billion by 2030

The retractable needle safety syringes market is projected to grow from $5.58 billion in 2025 to $8.13 billion by 2030, according to The Business Research Company. Growth is being driven by vaccination efforts, infection-control rules and rising concern over needlestick injuries.

Why it matters: - Retractable needle safety syringes are designed to reduce needlestick injuries and cross-contamination in healthcare settings. - The market’s growth signals stronger demand for safer injection tools as hospitals and clinics tighten safety and infection-control practices. - A reported CDC figure of about 385,000 needlestick and sharps-related injuries annually among U.S. hospital healthcare personnel shows why safer syringe designs remain a priority.

What happened: - The Business Research Company published a report on the retractable needle safety syringes market on Aug. 28, 2026. - The market is projected to rise from $5.58 billion in 2025 to $6.02 billion in 2026. - The report forecasts the market will reach $8.13 billion by 2030. - The report puts the market at a 8.0% CAGR from 2025 to 2026 and 7.8% CAGR through 2030. - North America held the largest share of the global market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Retractable needle safety syringes use a safety mechanism that withdraws the needle into the syringe barrel automatically or manually after use. - The devices are used for injections, vaccinations and blood collection. - The report links near-term growth to global vaccination programs, awareness of needle-stick injuries, stricter hospital safety policies, increased use of injectable drugs and wider availability of medical disposables. - Longer-term growth is tied to stricter regulations requiring safety syringes, broader immunization coverage, higher adoption of auto-disable syringes and more focus on protecting healthcare workers. - The report says rising use of auto-retractable syringes, disposable safety syringes, vaccination safety initiatives and infection-control protocols are shaping the market. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company added market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables to its 2026 reports. - The full report is available here, and a free sample is available here.

Between the lines: - The report points to a market shaped less by product novelty and more by regulation, worker safety and ongoing vaccination demand. - North America’s lead suggests mature safety standards are already supporting adoption, while Asia-Pacific’s growth outlook reflects expanding healthcare investment and immunization programs. - The CDC injury estimate adds context for why safety-engineered devices continue to gain traction beyond elective purchasing decisions.

What's next: - The report expects continued market expansion through 2030 as safety mandates and infection-prevention practices broaden. - Adoption of auto-retractable and auto-disable syringe designs is likely to keep rising as providers seek to lower exposure risks. - The market’s regional growth pattern will likely remain split between North America’s scale and Asia-Pacific’s faster expansion.